Clinical Trial Update: Apatinib Combined With POF for Second-line Treatment of Gastric Adenocarcinoma [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating apatinib combined with polypeptide- or POF for second-line treatment in gastric adenocarcinoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Adenocarcinoma

Drugs mentioned

• Apatinib (apatinib)

Snippet

Sponsor: Fujian Cancer Hospital | Conditions: Gastric Adenocarcinoma | Phase 2 | Status: UNKNOWN